Macclesfield, United Kingdom

Stuart Norman Lile Bennett

USPTO Granted Patents = 4 

Average Co-Inventor Count = 3.7

ph-index = 1


Location History:

  • Cheshire, GB (2006)
  • Macclesfield, GB (2011 - 2012)

Company Filing History:


Years Active: 2006-2012

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Stuart Norman Lile Bennett

Introduction

Stuart Norman Lile Bennett is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of therapeutic agents, holding a total of 4 patents. His work focuses on innovative compounds that have the potential to improve medical treatments.

Latest Patents

Among his latest patents, one includes a compound of Formula (I) that is useful in the treatment or prevention of diseases mediated through glucokinase (GLK or GK). This compound leads to a decreased glucose threshold for insulin secretion. Another patent features the compound (2S)-2-[1-(2-Chloro-6-cyano-phenyl)pyrazolo[4,5-e]pyrimidin-4-yl]oxy-3-[(1R)-2-hydroxy-1-methyl-ethoxy]-N-(5-methylpyrazin-2-yl)propanamide, which also serves a similar purpose in treating medical conditions related to glucokinase.

Career Highlights

Stuart is currently associated with AstraZeneca Ab, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on developing innovative therapeutic solutions that address critical health issues.

Collaborations

Throughout his career, Stuart has collaborated with esteemed colleagues such as Rolf Peter Walker and Michael James Waring. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Stuart Norman Lile Bennett's contributions to the field of therapeutic agents highlight his innovative spirit and dedication to improving healthcare. His patents reflect a commitment to addressing significant medical challenges through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…